» Articles » PMID: 34107984

Interobserver Variability in Target Volume Delineation in Definitive Radiotherapy for Thoracic Esophageal Cancer: a Multi-center Study from China

Abstract

Purpose: To investigate the interobserver variability (IOV) in target volume delineation of definitive radiotherapy for thoracic esophageal cancer (TEC) among cancer centers in China, and ultimately improve contouring consistency as much as possible to lay the foundation for multi-center prospective studies.

Methods: Sixteen cancer centers throughout China participated in this study. In Phase 1, three suitable cases with upper, middle, and lower TEC were chosen, and participants were asked to contour a group of gross tumor volume (GTV-T), nodal gross tumor volume (GTV-N) and clinical target volume (CTV) for each case based on their routine experience. In Phase 2, the same clinicians were instructed to follow a contouring protocol to re-contour another group of target volume. The variation of the target volume was analyzed and quantified using dice similarity coefficient (DSC).

Results: Sixteen clinicians provided routine volumes, whereas ten provided both routine and protocol volumes for each case. The IOV of routine GTV-N was the most striking in all cases, with the smallest DSC of 0.37 (95% CI 0.32-0.42), followed by CTV, whereas GTV-T showed high consistency. After following the protocol, the smallest DSC of GTV-N was improved to 0.64 (95% CI 0.45-0.83, P = 0.005) but the DSC of GTV-T and CTV remained constant in most cases.

Conclusion: Variability in target volume delineation was observed, but it could be significantly reduced and controlled using mandatory interventions.

Citing Articles

Contouring aid tools in radiotherapy. Smoothing: the false friend.

Marruecos Querol J, Jurado-Bruggeman D, Lopez-Vidal A, Nin R, Rubio-Casadevall J, Buxo M Clin Transl Oncol. 2024; 26(8):1956-1967.

PMID: 38493446 DOI: 10.1007/s12094-024-03420-9.


Fully-automated, CT-only GTV contouring for palliative head and neck radiotherapy.

Gay S, Cardenas C, Nguyen C, Netherton T, Yu C, Zhao Y Sci Rep. 2023; 13(1):21797.

PMID: 38066074 PMC: 10709623. DOI: 10.1038/s41598-023-48944-2.


Application of radiomics in adrenal incidentaloma: a literature review.

Li C, Fu Y, Yi X, Guan X, Liu L, Chen B Discov Oncol. 2022; 13(1):112.

PMID: 36305962 PMC: 9616972. DOI: 10.1007/s12672-022-00577-z.


Inter-Observer and Intra-Observer Variability in Gross Tumor Volume Delineation of Primary Esophageal Carcinomas Based on Different Combinations of Diagnostic Multimodal Images.

Li F, Li Y, Wang X, Zhang Y, Liu X, Liu S Front Oncol. 2022; 12:817413.

PMID: 35433413 PMC: 9010659. DOI: 10.3389/fonc.2022.817413.


Impact of Regional Lymph Node Irradiation on Reducing Lymph Node Recurrence in Esophageal Cancer Patients.

Watanabe S, Ogino I, Shigenaga D, Hata M Cancer Diagn Progn. 2022; 2(2):223-231.

PMID: 35399167 PMC: 8962802. DOI: 10.21873/cdp.10098.

References
1.
Foppiano F, Fiorino C, Frezza G, Greco C, Valdagni R . The impact of contouring uncertainty on rectal 3D dose-volume data: results of a dummy run in a multicenter trial (AIROPROS01-02). Int J Radiat Oncol Biol Phys. 2003; 57(2):573-9. DOI: 10.1016/s0360-3016(03)00659-x. View

2.
Bernard Davis J, Reiner B, Dusserre A, Giraud J, Bolla M . Quality assurance of the EORTC trial 22911. A phase III study of post-operative external radiotherapy in pathological stage T3N0 prostatic carcinoma: the dummy run. Radiother Oncol. 2002; 64(1):65-73. DOI: 10.1016/s0167-8140(02)00143-3. View

3.
Speicher P, Ganapathi A, Englum B, Hartwig M, Onaitis M, DAmico T . Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer. J Thorac Oncol. 2014; 9(8):1195-201. PMC: 4145610. DOI: 10.1097/JTO.0000000000000228. View

4.
Zhang J, Hooker C, Brock M, Shin J, Lee S, How R . Neoadjuvant chemoradiation therapy is beneficial for clinical stage T2 N0 esophageal cancer patients due to inaccurate preoperative staging. Ann Thorac Surg. 2012; 93(2):429-35. PMC: 4365971. DOI: 10.1016/j.athoracsur.2011.10.061. View

5.
Yamashita H, Takenaka R, Omori M, Imae T, Okuma K, Ohtomo K . Involved-field radiotherapy (IFRT) versus elective nodal irradiation (ENI) in combination with concurrent chemotherapy for 239 esophageal cancers: a single institutional retrospective study. Radiat Oncol. 2015; 10:171. PMC: 4554303. DOI: 10.1186/s13014-015-0482-9. View